title: Different phenotypes of lattice corneal dystrophy type I in patients with 417C>T (R124C) and 1762A>G (H572R) mutations in TGFBI (BIGH3).
abstract: OBJECTIVE
  To describe clinical data and to characterize mutations in the transforming growth factor beta-induced (TGFBI) gene in patients from three unrelated Chilean families with lattice corneal dystrophy type I (LCDI).
  
  
  METHODS
  Snellen acuity tests, anterior segment slit lamp examinations, dilated fundus evaluations, and tonometry were performed for seven patients--five females and two males belonging to three unrelated families--affected with lattice corneal dystrophy Type I. Genomic DNA was also extracted from peripheral leukocytes from the seven patients and four healthy relatives. The 417C>T mutation (R124C) was screened using PCR-RFLP for the seven patients and four healthy relatives. Exons 11, 12, 13, and 14 were sequenced in one patient not carrying the mutation in codon 124. Comparison of phenotype to genotype was performed.
  
  
  RESULTS
  The seven patients studied exhibited LCDI in both eyes, most of which were symmetric. Affected individuals demonstrated progression from central subepithelial needlelike deposits and polymorphic anterior stromal opacities. The age at onset of symptoms varied between six to 15 years old in Family One; the patient in Family Two was five years old and the patient in Family Three was 21 years old. Visual acuity varied from 1.0 to 0.05. Two patients, aged 50 and 45 years, underwent penetrating keratoplasty in both eyes, and two patients, aged 47 and 24 years, underwent penetrating keratoplasty in one eye. The only patient in Family Three exhibited a somewhat distinct phenotype, with yellowish discoloration in the anterior stroma and fewer, but thicker lattice lines than the patients in Families One and Two. Screening for the mutation C>T at the nucleotide position 417 (R124C) in exon 4 in the three families revealed the heterozygous R124C mutation in Families One and Two. In Family Two, the mutation was a de novo mutation, as neither parent was a carrier. Screening by sequencing analysis for mutation in exons 11, 12, 13, and 14 in the affected patient in Family Three revealed a heterozygous A1762G mutation (H572R) in exon 13.
  
  
  CONCLUSIONS
  This is the second report of the 417C>T mutation and the first report of 1762 A>G mutation (H572R) in Chilean patients. The H572R mutation identified is associated with a distinct lattice corneal dystrophy type I phenotype.
authors.affiliation: Depto. de Oftalmología, Hospital Clínico José Joaquín Aguirre, Universidad de Chile, Santiago, Chile.
authors.forename: Pablo
authors.initials: P
authors.lastname: Romero
authors.forename: Mauricio
authors.initials: M
authors.lastname: Moraga
authors.forename: Luisa
authors.initials: L
authors.lastname: Herrera
mesh_terms: D000328:Adult; D000369:Aged, 80 and over; D001483:Base Sequence; D003315:Cornea / Q000473:pathology; D003317:Corneal Dystrophies, Hereditary / Q000235:genetics* / Q000473:pathology*; D004252:DNA Mutational Analysis; D005091:Exons / Q000235:genetics; D016326:Extracellular Matrix Proteins / Q000235:genetics*; D005190:Family; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics*; D010375:Pedigree; D010641:Phenotype; D012150:Polymorphism, Restriction Fragment Length; D016212:Transforming Growth Factor beta / Q000235:genetics*; D055815:Young Adult; D000099222:betaIG-H3 Protein
chemical_list: D016326:Extracellular Matrix Proteins; D016212:Transforming Growth Factor beta; D000099222:betaIG-H3 Protein
references.citation: Nat Genet. 1994 Jan;6(1):47-51
references.pmid: 8136834
references.citation: Mol Vis. 2008 May 07;14:829-35
references.pmid: 18470323
references.citation: Eye (Lond). 2007 May;21(5):587-90
references.pmid: 16440005
references.citation: Am J Ophthalmol. 1998 Apr;125(4):547-9
references.pmid: 9559741
references.citation: Jpn J Ophthalmol. 2003 Jan-Feb;47(1):13-7
references.pmid: 12586172
references.citation: J Biol Chem. 1996 Jan 19;271(3):1314-21
references.pmid: 8576118
references.citation: Am J Pathol. 1967 Mar;50(3):371-99
references.pmid: 4163628
references.citation: J Biol Chem. 2009 Jul 17;284(29):19580-91
references.pmid: 19478074
references.citation: Mol Vis. 2003 Sep 11;9:440-8
references.pmid: 14502125
references.citation: Invest Ophthalmol Vis Sci. 2002 Apr;43(4):949-54
references.pmid: 11923233
references.citation: Am J Pathol. 1998 Mar;152(3):743-8
references.pmid: 9502416
references.citation: Br J Ophthalmol. 2003 Jun;87(6):686-9
references.pmid: 12770961
references.citation: Biochim Biophys Acta. 1999 Aug 12;1451(1):196-205
references.pmid: 10446401
references.citation: Hum Mutat. 1999;14(2):126-32
references.pmid: 10425035
references.citation: Am J Ophthalmol. 2004 Mar;137(3):586-8
references.pmid: 15013897
references.citation: Ophthalmologica. 2004 Nov-Dec;218(6):411-4
references.pmid: 15564760
references.citation: Arch Ophthalmol. 1999 Jan;117(1):67-75
references.pmid: 9930162
references.citation: Cornea. 2000 Nov;19(6):842-5
references.pmid: 11095060
references.citation: Mol Vis. 2006 May 10;12:461-6
references.pmid: 16710170
references.citation: Am J Ophthalmol. 1999 Dec;128(6):747-54
references.pmid: 10612512
references.citation: Ophthalmology. 2001 Apr;108(4):818-23
references.pmid: 11297504
references.citation: Nat Genet. 1997 Mar;15(3):247-51
references.pmid: 9054935
references.citation: J Cell Biochem. 2000 Mar;77(2):169-78
references.pmid: 10723084
references.citation: J Invest Dermatol. 1995 May;104(5):844-9
references.pmid: 7738366
references.citation: Curr Eye Res. 2000 Nov;21(5):891-6
references.pmid: 11262611
references.citation: Structure. 2003 Feb;11(2):197-203
references.pmid: 12575939
references.citation: Jpn J Ophthalmol. 2006 Sep-Oct;50(5):403-408
references.pmid: 17013691
references.citation: Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2213-9
references.pmid: 10476785
references.citation: Arch Ophthalmol. 2004 Aug;122(8):1224-7
references.pmid: 15302666
references.citation: Cell. 1988 May 20;53(4):577-87
references.pmid: 3370670
references.citation: Arch Ophthalmol. 1999 Jan;117(1):90-3
references.pmid: 9930165
references.citation: Nucleic Acids Res. 1991 Oct 11;19(19):5444
references.pmid: 1681511
references.citation: Invest Ophthalmol Vis Sci. 2000 May;41(6):1302-8
references.pmid: 10798644
references.citation: Am J Hum Genet. 1998 Feb;62(2):320-4
references.pmid: 9463327
references.citation: J Cell Physiol. 1994 Sep;160(3):511-21
references.pmid: 8077289
references.citation: DNA Cell Biol. 1992 Sep;11(7):511-22
references.pmid: 1388724
references.citation: Hum Mutat. 2006 Jul;27(7):615-25
references.pmid: 16683255